Eli Lilly Stock Hits Record as Insurance Coverage Expands for Zepbound - WSJ
Eli Lilly Stock Hits Record as Insurance Coverage Expands for Zepbound WSJ
Zepbound News
Cigna drops coverage of GLP-1 obesity drugs for its own employees - Reuters
Cigna drops coverage of GLP-1 obesity drugs for its own employees Reuters
Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available - Healthline
Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available Healthline
CVS will add these weight-loss options to drug plans - USA Today
CVS will add these weight-loss options to drug plans USA Today
Foundayo and Zepbound now covered for millions of Americans - PR Newswire
Foundayo and Zepbound now covered for millions of Americans PR Newswire
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash - NBC News
CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash NBC News
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans - CNBC
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans CNBC
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo - Fierce Pharma
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo Fierce Pharma
CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters
CVS brings back coverage for Lilly's obesity drug Zepbound Reuters
Orforglipron vs. Tirzepatide: What Are the Major Differences? - GoodRx
Orforglipron vs. Tirzepatide: What Are the Major Differences? GoodRx
Compounded GLP-1s: Why doctors worry and the FDA is cracking down - Stanford Medicine
Compounded GLP-1s: Why doctors worry and the FDA is cracking down Stanford Medicine
Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters
Study flags need to monitor frailty risks with GLP-1 drugs for older adults Reuters
GLP-1 Weight-Loss Drug Demonstration Begins July 2026 - Medicare Rights Center
GLP-1 Weight-Loss Drug Demonstration Begins July 2026 Medicare Rights Center
FDA receives applications for generic Mounjaro, Zepbound - NewsNation
FDA receives applications for generic Mounjaro, Zepbound NewsNation
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management - PR Newswire
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management PR Newswire
Wegovy Pill vs. Foundayo Pill: How the 2 New GLP-1 Drugs Compare - US News Health
Wegovy Pill vs. Foundayo Pill: How the 2 New GLP-1 Drugs Compare US News Health
GLP-1 weight loss drugs like Ozempic, Wegovy and Zepbound keep Long Island plastic surgeons busy - Newsday
GLP-1 weight loss drugs like Ozempic, Wegovy and Zepbound keep Long Island plastic surgeons busy Newsday
Zepbound vs. Wegovy For Weight Loss: What’s The Difference? - Forbes
Zepbound vs. Wegovy For Weight Loss: What’s The Difference? Forbes
Restrictions on obesity drug coverage force patients to pivot - NPR
Restrictions on obesity drug coverage force patients to pivot NPR
Zepbound Craze Fuels $1.3 Billion Windfall for Religious Causes - Bloomberg.com
Zepbound Craze Fuels $1.3 Billion Windfall for Religious Causes Bloomberg.com
Eligible seniors can get GLP-1s for $50 a month for weight loss alone - ABC News - Breaking News, Latest News and Videos
Eligible seniors can get GLP-1s for $50 a month for weight loss alone ABC News - Breaking News, Latest News and Videos
Zepbound: GLP-1s May Raise Frailty, Muscle Loss Risk in Older Adults - Healthline
Zepbound: GLP-1s May Raise Frailty, Muscle Loss Risk in Older Adults Healthline
GLP-1s 101: What the science says about weight loss, side effects, safety - Stanford Medicine
GLP-1s 101: What the science says about weight loss, side effects, safety Stanford Medicine
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - PR Newswire
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen PR Newswire
Zepbound Vs. Ozempic For Weight Loss: What’s The Difference? - Forbes
Zepbound Vs. Ozempic For Weight Loss: What’s The Difference? Forbes
Zepbound vs. Wegovy: Which GLP-1 Drug Is Best for Weight Loss? - Healthline
Zepbound vs. Wegovy: Which GLP-1 Drug Is Best for Weight Loss? Healthline
Wegovy, Zepbound: $50 GLP-1 Drugs Are Coming for Medicare Recipients - Healthline
Wegovy, Zepbound: $50 GLP-1 Drugs Are Coming for Medicare Recipients Healthline
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - PR Newswire
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials PR Newswire
How To Get Zepbound: Eligibility Criteria And Where To Buy - Forbes
How To Get Zepbound: Eligibility Criteria And Where To Buy Forbes
Zepbound® (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable - PR Newswire
Zepbound® (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable PR Newswire
How weight loss drugs are fueling a windfall for religious causes - The Seattle Times
How weight loss drugs are fueling a windfall for religious causes The Seattle Times
Insurance increasingly dropping weight loss drugs like Wegovy, Zepbound - Scripps News
Insurance increasingly dropping weight loss drugs like Wegovy, Zepbound Scripps News
Shaquille O’Neal Shares How Zepbound Helped with Sleep Apnea and Weight Loss - Healthline
Shaquille O’Neal Shares How Zepbound Helped with Sleep Apnea and Weight Loss Healthline
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect - Eli Lilly and Company
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect Eli Lilly and Company
Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices - UCHealth
Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices UCHealth
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site CNBC
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen - CNBC
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen CNBC
With Mass. cutting weight loss drug coverage, patients scramble to afford prescriptions - WBUR
With Mass. cutting weight loss drug coverage, patients scramble to afford prescriptions WBUR
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly and Company
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 Eli Lilly and Company
Is There a Generic for Zepbound? - Ro
Is There a Generic for Zepbound? Ro